Thursday, 25 December, 2025
GlobalData’s AI Tool Predicts Drug Approvals with ~85% Accuracy
GlobalData has developed an AI model that forecasts whether experimental drugs will gain U.S. approval with approximately 85.4% accuracy. The tool refines its Likelihood of Approval (LoA) predictions using extensive datasets, helping pharmaceutical companies streamline drug pipelines and allocate resources more strategically. By anticipating approval outcomes early, the model could accelerate R&D decisions and reduce costly trial failures in the biopharma sector.
Read full story at Economic Times